NCT05903092 2026-03-12
MOZART
Hoosier Cancer Research Network
Phase 2 Suspended
Clinical Trials
5 trialsNCT05061550 2026-03-11
NeoCOAST-2
AstraZeneca
Phase 2 Recruiting
NCT05221840 2026-01-27
PACIFIC-9
AstraZeneca
Phase 3 Active not recruiting
NCT06769126 2026-01-22
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
SWOG Cancer Research Network
Phase 2 Recruiting
NCT03801902 2025-09-23
Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial
National Cancer Institute (NCI)
Phase 1 Completed